Cost-effectiveness analysis of collaborative care management of major depression among low-income, predominantly Hispanics with diabetes

Joel W Hay, Wayne J Katon, Kathleen Ell, Pey-Jiuan Lee, Jeffrey J Guterman, Joel W Hay, Wayne J Katon, Kathleen Ell, Pey-Jiuan Lee, Jeffrey J Guterman

Abstract

Objective: To evaluate the cost-effectiveness of a socioculturally adapted collaborative depression care program among low-income Hispanics with diabetes.

Research design and methods: A randomized controlled trial of 387 patients with diabetes (96.5% Hispanic) with clinically significant depression followed over 18 months evaluated the cost-effectiveness of the Multifaceted Diabetes and Depression Program aimed at increasing patient exposure to evidence-based depression psychotherapy and/or pharmacotherapy in two public safety net clinics. Patient medical care costs and utilization were captured from Los Angeles County Department of Health Services claims records. Patient-reported outcomes included Short-Form Health Survey-12 and Patient Health Questionnaire-9-calculated depression-free days.

Results: Intervention patients had significantly greater Short-Form Health Survey-12 utility improvement from baseline compared with controls over the 18-month evaluation period (4.8%; P < 0.001) and a corresponding significant improvement in depression-free days (43.0; P < 0.001). Medical cost differences were not statistically significant in ordinary least squares and log-transformed cost regressions. The average costs of the Multifaceted Diabetes and Depression Program study intervention were $515 per patient. The program's cost-effectiveness averaged $4053 per quality-adjusted life-year per MDDP recipient and was more than 90% likely to fall below $12,000 per quality-adjusted life-year.

Conclusions: Socioculturally adapted collaborative depression care improved utility and quality of life in predominantly low-income Hispanic patients with diabetes and was highly cost-effective.

Trial registration: ClinicalTrials.gov NCT00709150.

Conflict of interest statement

No potential conflicts of interest relevant to this article were reported.

Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Figures

Figure 1
Figure 1
Cost Effectiveness Acceptability Curve.

References

    1. Center for Disease Control and Prevention, Health disparities experienced by Hispanics: United States. Morb Mortal Wkly Rep. 2004;53:935–937.
    1. National Center for Health Statistics. Health, United States, 2009: With Special Feature on Medical Technology. Hyattsville, MD: Department of Health and Human Services (DHHS) ; 2010. [Accessed July 11, 2011]. Table 51. Publication No. 2010-1232. Available at: .
    1. Black SA, Ray LA, Markides KS. The prevalence and health burden of self-reported diabetes in older Mexican Americans: findings from the Hispanic established populations for epidemiologic studies of the elderly. Am J Public Health. 1999;89:546–552.
    1. Gross R, Olfson M, Gameroff MJ, et al. Depression and glycemic control in Hispanic primary care patients with diabetes. J Gen Intern Med. 2005;20:460–466.
    1. Li C, Ford ES, Strine TW, Mokdad AH. Prevalence of depression among U.S. adults with diabetes: findings from the 2006 behavioral risk factor surveillance system. Diabetes Care. 2008;31:105–107.
    1. Cabassa LJ, Hansen MC, Palinkas LA, Ell K. Azúcar y Nervios: Explanatory models and treatment experiences of Hispanics with diabetes and depression. Soc Sci & Med. 2008;66:2413–2424.
    1. United States Department of Health and Human Services. A report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services; 2001. Mental health: Culture, race, and ethnicity: A supplement to mental health.
    1. Borowsky SJ, Rubenstein LV, Meredith LS, et al. Who is at risk of nondetection of mental health problems in primary care? J Gen Intern Med. 2000;15:381–388.
    1. Rodriguez HP, Chen J, Rodriguez MA. A national study of problematic care experiences among Latinos with diabetes. J Health Care Poor Underserved. 2010;21:1152–1168.
    1. Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry. 2006;163:101–108.
    1. Pinto-Meza A, Fernandez A, Serrano-Blanco A, Haro JM. Adequacy of antidepressant treatment in Spanish primary care: a naturalistic six-month follow-up study. Psychiatr Serv. 2008;59:78–83.
    1. Ell K, Katon W, Xie B, et al. Collaborative care management of major depression among low-income, predominantly Hispanics with diabetes: a randomized controlled trial. Diabetes Care. 2010;33:706–713.
    1. Katon WJ, Rutter C, Simon G, et al. The association of comorbid depression with mortality in patients with Type 2 diabetes. Diabetes Care. 2005;28:2668–2672.
    1. Katon WJ, Unűtzer J, Fan M-Y, et al. Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care. 2006;29:265–270.
    1. Simon GE, Katon WJ, Lin EHB, et al. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus. Arch Gen Psychiatry. 2007;64:65–72.
    1. Vannoy SD, Arean P, Unűtzer J. Advantages of using estimated depression-free days for evaluating treatment efficacy. Psychiatric Services. 2010;61:160–163.
    1. Wittkampf KA, Naeije L, Schene AH, et al. Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review. Gen Hosp Psych. 2007;29:388–395.
    1. Huang FY, Chung H, Kroenke K, et al. Using the Patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients. J Gen Intern Med. 2006;21:547–552.
    1. Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42:851–859.
    1. [Accessed June, 2009];RBRVS EZ-Fees. 2011
    1. [Accessed June, 2009];United States Department of Veterans Affairs. .
    1. Myer B. Natural and Quasi-Experiments in Economics. J Bus Econ Stat. 1995;13:151–161.
    1. Bertrand M, Duflo E, Mullainathan S. How much should we trust differences-in-differences estimates?". Quarterly J Econ. 2004;119:249–275.
    1. Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ. 1998;17:283–295.
    1. Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20:461–494.
    1. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41–55.
    1. Glick HA, Briggs AH, Polsky D. Quantifying stochastic uncertainty and presenting the results of cost effectiveness analyses. Expert Rev Pharmacoecon Outcomes Res 1. 2001:89–100.
    1. Hay JW. Using pharmacoeconomics to value pharmacotherapy. Clin Pharmacol Therapeutics. 2008;84:197–200.
    1. Murphy KM, Topel RH, editors. Measuring the Gains from Medical Research: An Economic Approach. Chicago, IL: University of Chicago Press; 2003.
    1. Nordhaus W. NBER Working Paper Series 8818. Cambridge, MA: National Bureau of Economic Research; 2002. The Health of Nations: The Contribution of Improved Health to Living Standards.
    1. Jeffrey D, Sachs, et al. Report of the Commission on Macroeconomics and Health. World Health Organization; 2001. Dec, Macroeconomics and Health: Investing in Health for Economic Development.
    1. Viscusi WK. The Value Of Life: Estimates With Risks By Occupation And Industry. ISSN Discussion Paper Series No. 422 05/2003
    1. Katon WJ, Russo JE, Von Korff M, et al. Long-term effects on medical costs of improving depression outcomes in patients with depression and diabetes. Diabetes Care. 2008;31:1155–1159.
    1. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in Mexican Americans with type 2 diabetes. Diabetes Care. 2003;26:2822–2828.
    1. Lin EH, Rutter CM, Katon W, et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care. 2010;33:264–269.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera